

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of erythrocyte differentiation (GO:0045647) | 5.93497441 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.85356118 |
| 3 | positive regulation of B cell differentiation (GO:0045579) | 5.22500588 |
| 4 | neutrophil activation involved in immune response (GO:0002283) | 5.09339500 |
| 5 | response to peptidoglycan (GO:0032494) | 4.93380470 |
| 6 | immunoglobulin mediated immune response (GO:0016064) | 4.27484278 |
| 7 | regulation of mast cell degranulation (GO:0043304) | 4.23204243 |
| 8 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.15974763 |
| 9 | regulation of gamma-delta T cell activation (GO:0046643) | 4.10918203 |
| 10 | cellular extravasation (GO:0045123) | 4.03282503 |
| 11 | regulation of hypersensitivity (GO:0002883) | 3.92530293 |
| 12 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.90402633 |
| 13 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.82568629 |
| 14 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.80335414 |
| 15 | response to muramyl dipeptide (GO:0032495) | 3.70466838 |
| 16 | definitive hemopoiesis (GO:0060216) | 3.69935042 |
| 17 | regulation of B cell differentiation (GO:0045577) | 3.68505540 |
| 18 | regulation of leukocyte degranulation (GO:0043300) | 3.61244908 |
| 19 | mannose metabolic process (GO:0006013) | 3.59907945 |
| 20 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.53205912 |
| 21 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.53205912 |
| 22 | modulation by symbiont of host immune response (GO:0052553) | 3.53205912 |
| 23 | positive regulation by symbiont of host defense response (GO:0052509) | 3.53205912 |
| 24 | modulation by symbiont of host defense response (GO:0052031) | 3.53205912 |
| 25 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.53205912 |
| 26 | poly(A)+ mRNA export from nucleus (GO:0016973) | 3.53143781 |
| 27 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.50830257 |
| 28 | B cell receptor signaling pathway (GO:0050853) | 3.47013635 |
| 29 | respiratory burst (GO:0045730) | 3.42353961 |
| 30 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.36746539 |
| 31 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.33987221 |
| 32 | B cell mediated immunity (GO:0019724) | 3.31970630 |
| 33 | pinocytosis (GO:0006907) | 3.31565203 |
| 34 | germinal center formation (GO:0002467) | 3.26313403 |
| 35 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.26030314 |
| 36 | detection of other organism (GO:0098543) | 3.24212072 |
| 37 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.23657823 |
| 38 | Peyers patch development (GO:0048541) | 3.23657823 |
| 39 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.23117436 |
| 40 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.22677886 |
| 41 | regulation of mast cell activation (GO:0033003) | 3.22493878 |
| 42 | negative regulation of interleukin-12 production (GO:0032695) | 3.15699362 |
| 43 | megakaryocyte development (GO:0035855) | 3.15593840 |
| 44 | neutrophil activation (GO:0042119) | 3.14221995 |
| 45 | leukocyte degranulation (GO:0043299) | 3.13421527 |
| 46 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.10876675 |
| 47 | negative regulation of T cell mediated immunity (GO:0002710) | 3.06020154 |
| 48 | regulation of vitamin metabolic process (GO:0030656) | 3.05707583 |
| 49 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.03185890 |
| 50 | positive regulation of mast cell degranulation (GO:0043306) | 3.02429226 |
| 51 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.02429226 |
| 52 | detection of bacterium (GO:0016045) | 3.01164312 |
| 53 | macrophage differentiation (GO:0030225) | 3.00413694 |
| 54 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.99743067 |
| 55 | response to thyroid hormone (GO:0097066) | 2.99104658 |
| 56 | positive regulation of granulocyte differentiation (GO:0030854) | 2.96228467 |
| 57 | granulocyte activation (GO:0036230) | 2.94256639 |
| 58 | positive regulation of mast cell activation (GO:0033005) | 2.92157154 |
| 59 | actin nucleation (GO:0045010) | 2.91778357 |
| 60 | negative regulation of granulocyte differentiation (GO:0030853) | 2.90557222 |
| 61 | myeloid cell activation involved in immune response (GO:0002275) | 2.90303838 |
| 62 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.90122592 |
| 63 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.89828992 |
| 64 | glycosphingolipid catabolic process (GO:0046479) | 2.89189194 |
| 65 | regulation of regulated secretory pathway (GO:1903305) | 2.87439813 |
| 66 | T cell migration (GO:0072678) | 2.87275915 |
| 67 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.86922651 |
| 68 | negative regulation of cell killing (GO:0031342) | 2.86922651 |
| 69 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.85895645 |
| 70 | positive thymic T cell selection (GO:0045059) | 2.83494778 |
| 71 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.82337554 |
| 72 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.81811342 |
| 73 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.77792560 |
| 74 | leukocyte aggregation (GO:0070486) | 2.76040290 |
| 75 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.75738935 |
| 76 | negative thymic T cell selection (GO:0045060) | 2.73770354 |
| 77 | cellular response to exogenous dsRNA (GO:0071360) | 2.71890405 |
| 78 | tolerance induction (GO:0002507) | 2.70698725 |
| 79 | response to protozoan (GO:0001562) | 2.69606535 |
| 80 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.67205731 |
| 81 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.66469378 |
| 82 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.65152880 |
| 83 | regulation of erythrocyte differentiation (GO:0045646) | 2.64938103 |
| 84 | negative regulation of interleukin-6 production (GO:0032715) | 2.64650029 |
| 85 | angiotensin maturation (GO:0002003) | 2.64509475 |
| 86 | regulation of granulocyte differentiation (GO:0030852) | 2.61967823 |
| 87 | glycolipid catabolic process (GO:0019377) | 2.61902128 |
| 88 | regulation of acute inflammatory response to antigenic stimulus (GO:0002864) | 2.60134814 |
| 89 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.59478170 |
| 90 | regulation of tolerance induction (GO:0002643) | 2.58655935 |
| 91 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.58124968 |
| 92 | positive regulation of antigen processing and presentation (GO:0002579) | 2.57546076 |
| 93 | regulation of antigen processing and presentation (GO:0002577) | 2.56880854 |
| 94 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.54714938 |
| 95 | cell wall macromolecule catabolic process (GO:0016998) | 2.54217672 |
| 96 | hyaluronan catabolic process (GO:0030214) | 2.53891760 |
| 97 | macrophage activation involved in immune response (GO:0002281) | 2.52656999 |
| 98 | negative T cell selection (GO:0043383) | 2.51570084 |
| 99 | detection of external biotic stimulus (GO:0098581) | 2.51538223 |
| 100 | mature B cell differentiation involved in immune response (GO:0002313) | 2.51383200 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.83398828 |
| 2 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.94506213 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.86327144 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.32306835 |
| 5 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.31148423 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.31138369 |
| 7 | * VDR_24763502_ChIP-Seq_THP-1_Human | 3.27509257 |
| 8 | MYC_22102868_ChIP-Seq_BL_Human | 2.97227693 |
| 9 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.85314462 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.82311505 |
| 11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.74767190 |
| 12 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.69275286 |
| 13 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.65455857 |
| 14 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.60548692 |
| 15 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.52733055 |
| 16 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.40037230 |
| 17 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.38858498 |
| 18 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.35197413 |
| 19 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.32165320 |
| 20 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.26479566 |
| 21 | MYB_26560356_Chip-Seq_TH2_Human | 2.19303085 |
| 22 | SPI1_23127762_ChIP-Seq_K562_Human | 2.19270272 |
| 23 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.16624320 |
| 24 | MAF_26560356_Chip-Seq_TH1_Human | 2.15193667 |
| 25 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.10673551 |
| 26 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.09651232 |
| 27 | GATA1_22025678_ChIP-Seq_K562_Human | 2.07608107 |
| 28 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.02986123 |
| 29 | UTX_26944678_Chip-Seq_JUKART_Human | 2.01711848 |
| 30 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.94676666 |
| 31 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.89138677 |
| 32 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.86519778 |
| 33 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.85569442 |
| 34 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.82900367 |
| 35 | MYB_26560356_Chip-Seq_TH1_Human | 1.80836740 |
| 36 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73650713 |
| 37 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73106612 |
| 38 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.71725615 |
| 39 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69017777 |
| 40 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.69004724 |
| 41 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.68360245 |
| 42 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.68327651 |
| 43 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.66747395 |
| 44 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.66094937 |
| 45 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.58275243 |
| 46 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.57394742 |
| 47 | MAF_26560356_Chip-Seq_TH2_Human | 1.56059376 |
| 48 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.55989271 |
| 49 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.55604073 |
| 50 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.55400359 |
| 51 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.54551891 |
| 52 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.54121022 |
| 53 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.53753760 |
| 54 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.52391829 |
| 55 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.52318902 |
| 56 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.51313615 |
| 57 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.47959833 |
| 58 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.46495645 |
| 59 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46359920 |
| 60 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.43286625 |
| 61 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.41441701 |
| 62 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.39388297 |
| 63 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.38984380 |
| 64 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.38075569 |
| 65 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.37783782 |
| 66 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.35269623 |
| 67 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35241708 |
| 68 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.30810382 |
| 69 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.29210204 |
| 70 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.29121349 |
| 71 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.28825867 |
| 72 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27206452 |
| 73 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25468036 |
| 74 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.17752902 |
| 75 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.13892688 |
| 76 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.13341149 |
| 77 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13135861 |
| 78 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.12709995 |
| 79 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.12166479 |
| 80 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10852661 |
| 81 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.08861958 |
| 82 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.06558678 |
| 83 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.02190249 |
| 84 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00264666 |
| 85 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00236718 |
| 86 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.99300377 |
| 87 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.98121886 |
| 88 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.98034957 |
| 89 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.97799826 |
| 90 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97430993 |
| 91 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.97212950 |
| 92 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.96527513 |
| 93 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.96001668 |
| 94 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.95935719 |
| 95 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95907021 |
| 96 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.95048348 |
| 97 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94955489 |
| 98 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92504535 |
| 99 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.91285528 |
| 100 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.88649936 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 3.70666922 |
| 2 | MP0003436_decreased_susceptibility_to | 3.55536131 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.38359901 |
| 4 | MP0005464_abnormal_platelet_physiology | 3.10208675 |
| 5 | MP0002419_abnormal_innate_immunity | 2.93652311 |
| 6 | MP0003300_gastrointestinal_ulcer | 2.86009477 |
| 7 | MP0003724_increased_susceptibility_to | 2.80015052 |
| 8 | MP0005025_abnormal_response_to | 2.73202470 |
| 9 | MP0005058_abnormal_lysosome_morphology | 2.70094207 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.66107856 |
| 11 | MP0002148_abnormal_hypersensitivity_rea | 2.58220480 |
| 12 | MP0005671_abnormal_response_to | 2.53047575 |
| 13 | MP0002396_abnormal_hematopoietic_system | 2.37351162 |
| 14 | MP0001790_abnormal_immune_system | 2.31318265 |
| 15 | MP0005387_immune_system_phenotype | 2.31318265 |
| 16 | MP0001800_abnormal_humoral_immune | 2.30833845 |
| 17 | MP0003172_abnormal_lysosome_physiology | 2.26730949 |
| 18 | MP0002420_abnormal_adaptive_immunity | 2.25674912 |
| 19 | MP0002723_abnormal_immune_serum | 2.24333981 |
| 20 | MP0000465_gastrointestinal_hemorrhage | 2.24172430 |
| 21 | MP0001819_abnormal_immune_cell | 2.23595126 |
| 22 | MP0009785_altered_susceptibility_to | 2.22639550 |
| 23 | MP0002452_abnormal_antigen_presenting | 2.21410970 |
| 24 | MP0006082_CNS_inflammation | 2.17968391 |
| 25 | MP0009278_abnormal_bone_marrow | 2.12302195 |
| 26 | MP0005397_hematopoietic_system_phenotyp | 2.08654532 |
| 27 | MP0001545_abnormal_hematopoietic_system | 2.08654532 |
| 28 | MP0009840_abnormal_foam_cell | 2.05708585 |
| 29 | MP0000685_abnormal_immune_system | 1.96937113 |
| 30 | MP0002398_abnormal_bone_marrow | 1.95955403 |
| 31 | MP0003763_abnormal_thymus_physiology | 1.93487616 |
| 32 | MP0009333_abnormal_splenocyte_physiolog | 1.91729782 |
| 33 | MP0010155_abnormal_intestine_physiology | 1.91639659 |
| 34 | MP0000716_abnormal_immune_system | 1.83573773 |
| 35 | MP0001845_abnormal_inflammatory_respons | 1.78837272 |
| 36 | MP0003191_abnormal_cellular_cholesterol | 1.74334511 |
| 37 | MP0002405_respiratory_system_inflammati | 1.71267609 |
| 38 | MP0000689_abnormal_spleen_morphology | 1.71005408 |
| 39 | MP0002722_abnormal_immune_system | 1.70230701 |
| 40 | MP0004947_skin_inflammation | 1.65631804 |
| 41 | MP0004808_abnormal_hematopoietic_stem | 1.64593956 |
| 42 | MP0001853_heart_inflammation | 1.64076201 |
| 43 | MP0005360_urolithiasis | 1.62702602 |
| 44 | MP0002429_abnormal_blood_cell | 1.62452695 |
| 45 | MP0003656_abnormal_erythrocyte_physiolo | 1.61400606 |
| 46 | MP0001533_abnormal_skeleton_physiology | 1.56905946 |
| 47 | MP0009764_decreased_sensitivity_to | 1.46936646 |
| 48 | MP0008469_abnormal_protein_level | 1.45143630 |
| 49 | MP0009379_abnormal_foot_pigmentation | 1.44277786 |
| 50 | MP0003828_pulmonary_edema | 1.43426577 |
| 51 | MP0002009_preneoplasia | 1.41348093 |
| 52 | MP0003866_abnormal_defecation | 1.39861543 |
| 53 | MP0000343_altered_response_to | 1.38486331 |
| 54 | MP0000703_abnormal_thymus_morphology | 1.37640404 |
| 55 | MP0005451_abnormal_body_composition | 1.35345438 |
| 56 | MP0002166_altered_tumor_susceptibility | 1.27294420 |
| 57 | MP0003183_abnormal_peptide_metabolism | 1.26392185 |
| 58 | MP0003806_abnormal_nucleotide_metabolis | 1.25912373 |
| 59 | MP0002877_abnormal_melanocyte_morpholog | 1.24593155 |
| 60 | MP0000490_abnormal_crypts_of | 1.18326728 |
| 61 | MP0000604_amyloidosis | 1.18000184 |
| 62 | MP0002132_abnormal_respiratory_system | 1.14902724 |
| 63 | MP0002998_abnormal_bone_remodeling | 1.13250451 |
| 64 | MP0000858_altered_metastatic_potential | 1.09330871 |
| 65 | MP0003075_altered_response_to | 1.09275542 |
| 66 | MP0003448_altered_tumor_morphology | 1.08901362 |
| 67 | MP0009763_increased_sensitivity_to | 1.05656270 |
| 68 | MP0001851_eye_inflammation | 1.02646358 |
| 69 | MP0005310_abnormal_salivary_gland | 0.98623011 |
| 70 | MP0002006_tumorigenesis | 0.95077684 |
| 71 | MP0005166_decreased_susceptibility_to | 0.94740369 |
| 72 | MP0009765_abnormal_xenobiotic_induced | 0.87474477 |
| 73 | MP0004782_abnormal_surfactant_physiolog | 0.86646299 |
| 74 | MP0008004_abnormal_stomach_pH | 0.85662864 |
| 75 | MP0001663_abnormal_digestive_system | 0.85315871 |
| 76 | MP0004264_abnormal_extraembryonic_tissu | 0.83924598 |
| 77 | MP0001873_stomach_inflammation | 0.81769191 |
| 78 | MP0005076_abnormal_cell_differentiation | 0.78953916 |
| 79 | MP0000249_abnormal_blood_vessel | 0.77760032 |
| 80 | MP0000609_abnormal_liver_physiology | 0.77335492 |
| 81 | MP0005167_abnormal_blood-brain_barrier | 0.76794223 |
| 82 | MP0010307_abnormal_tumor_latency | 0.73878850 |
| 83 | MP0002139_abnormal_hepatobiliary_system | 0.73226100 |
| 84 | MP0002138_abnormal_hepatobiliary_system | 0.73034072 |
| 85 | MP0002019_abnormal_tumor_incidence | 0.73022870 |
| 86 | MP0000015_abnormal_ear_pigmentation | 0.72994424 |
| 87 | MP0008260_abnormal_autophagy | 0.72776317 |
| 88 | MP0009115_abnormal_fat_cell | 0.68713038 |
| 89 | MP0004147_increased_porphyrin_level | 0.68135052 |
| 90 | MP0005535_abnormal_body_temperature | 0.67225236 |
| 91 | MP0005174_abnormal_tail_pigmentation | 0.65979656 |
| 92 | MP0003795_abnormal_bone_structure | 0.65367151 |
| 93 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.64323772 |
| 94 | MP0005164_abnormal_response_to | 0.63698140 |
| 95 | MP0005075_abnormal_melanosome_morpholog | 0.62259574 |
| 96 | MP0005319_abnormal_enzyme/_coenzyme | 0.61685910 |
| 97 | MP0000681_abnormal_thyroid_gland | 0.61279754 |
| 98 | MP0005365_abnormal_bile_salt | 0.60409772 |
| 99 | MP0005390_skeleton_phenotype | 0.59249272 |
| 100 | MP0009931_abnormal_skin_appearance | 0.57379215 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.21130247 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 4.93278323 |
| 3 | Abnormality of macrophages (HP:0004311) | 4.43202126 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.41483835 |
| 5 | Eczematoid dermatitis (HP:0000976) | 4.32655389 |
| 6 | Systemic lupus erythematosus (HP:0002725) | 4.21141669 |
| 7 | Stomatitis (HP:0010280) | 4.08140363 |
| 8 | Petechiae (HP:0000967) | 3.90311727 |
| 9 | Myositis (HP:0100614) | 3.87476328 |
| 10 | Chronic obstructive pulmonary disease (HP:0006510) | 3.72753661 |
| 11 | Obstructive lung disease (HP:0006536) | 3.72753661 |
| 12 | Recurrent viral infections (HP:0004429) | 3.66886464 |
| 13 | Prolonged bleeding time (HP:0003010) | 3.63900248 |
| 14 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.49333265 |
| 15 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.49333265 |
| 16 | Abnormality of glycolipid metabolism (HP:0010969) | 3.49333265 |
| 17 | Recurrent fungal infections (HP:0002841) | 3.47885695 |
| 18 | Thrombocytosis (HP:0001894) | 3.47803823 |
| 19 | Recurrent skin infections (HP:0001581) | 3.36072726 |
| 20 | Amyloidosis (HP:0011034) | 3.33975708 |
| 21 | Mediastinal lymphadenopathy (HP:0100721) | 3.25946710 |
| 22 | Meningitis (HP:0001287) | 3.25139399 |
| 23 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.19113875 |
| 24 | Recurrent cutaneous fungal infections (HP:0011370) | 3.19113875 |
| 25 | Granulocytopenia (HP:0001913) | 3.17195101 |
| 26 | Abnormality of B cell number (HP:0010975) | 3.03684137 |
| 27 | Cellulitis (HP:0100658) | 3.01302129 |
| 28 | Vacuolated lymphocytes (HP:0001922) | 3.00286974 |
| 29 | Abnormal platelet function (HP:0011869) | 2.98797691 |
| 30 | Impaired platelet aggregation (HP:0003540) | 2.98797691 |
| 31 | Dysostosis multiplex (HP:0000943) | 2.94801993 |
| 32 | B lymphocytopenia (HP:0010976) | 2.94360054 |
| 33 | Panhypogammaglobulinemia (HP:0003139) | 2.91287605 |
| 34 | Acute lymphatic leukemia (HP:0006721) | 2.90852397 |
| 35 | Spontaneous hematomas (HP:0007420) | 2.89619162 |
| 36 | Pustule (HP:0200039) | 2.88560163 |
| 37 | Encephalitis (HP:0002383) | 2.88252086 |
| 38 | Increased cerebral lipofuscin (HP:0011813) | 2.86000992 |
| 39 | Agammaglobulinemia (HP:0004432) | 2.84470456 |
| 40 | Epistaxis (HP:0000421) | 2.83886300 |
| 41 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.82497147 |
| 42 | Abnormality of the prostate (HP:0008775) | 2.82171258 |
| 43 | Gingivitis (HP:0000230) | 2.78032672 |
| 44 | Purpura (HP:0000979) | 2.76478109 |
| 45 | Vasculitis (HP:0002633) | 2.76072180 |
| 46 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.73973517 |
| 47 | Hepatosplenomegaly (HP:0001433) | 2.72821811 |
| 48 | Increased IgE level (HP:0003212) | 2.71358232 |
| 49 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.66989562 |
| 50 | Orchitis (HP:0100796) | 2.66863652 |
| 51 | Urticaria (HP:0001025) | 2.62604886 |
| 52 | Thoracic kyphosis (HP:0002942) | 2.60961887 |
| 53 | Acute myeloid leukemia (HP:0004808) | 2.56549422 |
| 54 | Osteomyelitis (HP:0002754) | 2.55259035 |
| 55 | Leukocytosis (HP:0001974) | 2.53901659 |
| 56 | Autoimmune thrombocytopenia (HP:0001973) | 2.53041524 |
| 57 | Increased serum ferritin (HP:0003281) | 2.51666570 |
| 58 | Colitis (HP:0002583) | 2.50225540 |
| 59 | Inflammation of the large intestine (HP:0002037) | 2.42606518 |
| 60 | Abnormality of complement system (HP:0005339) | 2.42007800 |
| 61 | Hemoptysis (HP:0002105) | 2.40078556 |
| 62 | Gastrointestinal inflammation (HP:0004386) | 2.39950199 |
| 63 | Episodic fever (HP:0001954) | 2.36854603 |
| 64 | Glomerulonephritis (HP:0000099) | 2.34766672 |
| 65 | Chest pain (HP:0100749) | 2.31833882 |
| 66 | Interstitial pulmonary disease (HP:0006530) | 2.30511967 |
| 67 | Abnormality of the lumbar spine (HP:0100712) | 2.29204448 |
| 68 | Abnormality of T cell physiology (HP:0011840) | 2.28906054 |
| 69 | Hypergammaglobulinemia (HP:0010702) | 2.27050874 |
| 70 | Skin rash (HP:0000988) | 2.25996733 |
| 71 | Retrobulbar optic neuritis (HP:0100654) | 2.24126342 |
| 72 | Optic neuritis (HP:0100653) | 2.24126342 |
| 73 | Premature loss of primary teeth (HP:0006323) | 2.21467153 |
| 74 | Abnormality of iron homeostasis (HP:0011031) | 2.21064339 |
| 75 | Gingival bleeding (HP:0000225) | 2.17001480 |
| 76 | Abnormality of T cells (HP:0002843) | 2.16413766 |
| 77 | Loss of speech (HP:0002371) | 2.16072933 |
| 78 | Gastrointestinal infarctions (HP:0005244) | 2.15194768 |
| 79 | Arterial thrombosis (HP:0004420) | 2.11738095 |
| 80 | Autoimmune hemolytic anemia (HP:0001890) | 2.11058171 |
| 81 | Chronic otitis media (HP:0000389) | 2.10788246 |
| 82 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.01824337 |
| 83 | IgM deficiency (HP:0002850) | 2.00527483 |
| 84 | Complement deficiency (HP:0004431) | 1.99191287 |
| 85 | Aplastic anemia (HP:0001915) | 1.99169939 |
| 86 | Pulmonary infiltrates (HP:0002113) | 1.97690646 |
| 87 | Abnormality of the thoracic spine (HP:0100711) | 1.95688640 |
| 88 | Skin ulcer (HP:0200042) | 1.94726765 |
| 89 | Joint swelling (HP:0001386) | 1.92735899 |
| 90 | Malnutrition (HP:0004395) | 1.91782426 |
| 91 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.89395972 |
| 92 | Keratoconjunctivitis sicca (HP:0001097) | 1.89259961 |
| 93 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.87419664 |
| 94 | Pulmonary embolism (HP:0002204) | 1.87364285 |
| 95 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.85319959 |
| 96 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.85319959 |
| 97 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.85319959 |
| 98 | Eosinophilia (HP:0001880) | 1.84033754 |
| 99 | Pulmonary fibrosis (HP:0002206) | 1.83205875 |
| 100 | Mucopolysacchariduria (HP:0008155) | 1.82597980 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 5.01392570 |
| 2 | FES | 3.09348294 |
| 3 | ERN1 | 3.07709703 |
| 4 | MAP4K1 | 2.81388144 |
| 5 | PRPF4B | 2.79189955 |
| 6 | MAP3K14 | 2.74487723 |
| 7 | MATK | 2.67466618 |
| 8 | KIT | 2.51474755 |
| 9 | BLK | 2.44127419 |
| 10 | BTK | 2.39540254 |
| 11 | NME2 | 2.27661709 |
| 12 | MAP2K3 | 2.11183148 |
| 13 | TYK2 | 2.07261277 |
| 14 | TEC | 2.00993498 |
| 15 | TBK1 | 2.00708300 |
| 16 | IRAK3 | 1.97595976 |
| 17 | ZAP70 | 1.89561691 |
| 18 | GRK6 | 1.88507817 |
| 19 | SYK | 1.84066155 |
| 20 | MAP3K6 | 1.76873554 |
| 21 | MAP3K13 | 1.61256071 |
| 22 | LYN | 1.60133407 |
| 23 | TRIB3 | 1.60071612 |
| 24 | CSF1R | 1.54569816 |
| 25 | TAOK3 | 1.53514672 |
| 26 | RPS6KA4 | 1.50417770 |
| 27 | TXK | 1.49932788 |
| 28 | CSK | 1.46577327 |
| 29 | EEF2K | 1.46295254 |
| 30 | BMPR2 | 1.45003263 |
| 31 | IRAK4 | 1.44310344 |
| 32 | TNK2 | 1.40448983 |
| 33 | JAK3 | 1.38376731 |
| 34 | CLK1 | 1.36222337 |
| 35 | CDK6 | 1.34818960 |
| 36 | HCK | 1.33820659 |
| 37 | ITK | 1.28560010 |
| 38 | MAP3K1 | 1.21384009 |
| 39 | JAK1 | 1.19605920 |
| 40 | JAK2 | 1.18840439 |
| 41 | IKBKB | 1.12558731 |
| 42 | LCK | 1.12089077 |
| 43 | IKBKE | 1.11776321 |
| 44 | LRRK2 | 1.10035151 |
| 45 | PKN2 | 1.01073709 |
| 46 | TAOK2 | 0.92562344 |
| 47 | FGR | 0.87297047 |
| 48 | PDPK1 | 0.83806292 |
| 49 | SMG1 | 0.83464672 |
| 50 | HIPK2 | 0.82852034 |
| 51 | ICK | 0.80953278 |
| 52 | PIM1 | 0.80599432 |
| 53 | MAP2K2 | 0.79963374 |
| 54 | TESK2 | 0.77423378 |
| 55 | CDK4 | 0.76740653 |
| 56 | PDK1 | 0.76458542 |
| 57 | MAP3K11 | 0.76161943 |
| 58 | BMX | 0.71236836 |
| 59 | MAPK12 | 0.70444431 |
| 60 | YES1 | 0.68317905 |
| 61 | STK10 | 0.68146359 |
| 62 | RPS6KL1 | 0.65805239 |
| 63 | RPS6KC1 | 0.65805239 |
| 64 | MARK2 | 0.65281746 |
| 65 | MAPK11 | 0.64441695 |
| 66 | MAP3K8 | 0.63854863 |
| 67 | PRKCQ | 0.63405919 |
| 68 | FLT3 | 0.59790918 |
| 69 | RET | 0.56948230 |
| 70 | PIK3CG | 0.55668550 |
| 71 | SCYL2 | 0.55090287 |
| 72 | FGFR3 | 0.54947869 |
| 73 | MAPK4 | 0.54557053 |
| 74 | MARK3 | 0.52524074 |
| 75 | RPS6KA6 | 0.50242752 |
| 76 | TGFBR2 | 0.47697738 |
| 77 | KSR2 | 0.44639474 |
| 78 | MAPK3 | 0.44376857 |
| 79 | MAP2K6 | 0.43331560 |
| 80 | IRAK2 | 0.42737207 |
| 81 | PTK6 | 0.42253701 |
| 82 | TRPM7 | 0.41418676 |
| 83 | CDK12 | 0.40416630 |
| 84 | SIK3 | 0.38787844 |
| 85 | TAOK1 | 0.37661029 |
| 86 | ALK | 0.35950482 |
| 87 | IRAK1 | 0.35751464 |
| 88 | ABL1 | 0.35729765 |
| 89 | FYN | 0.35437487 |
| 90 | MAPKAPK2 | 0.33559428 |
| 91 | CDK19 | 0.32357169 |
| 92 | CDK3 | 0.32277514 |
| 93 | MAP3K5 | 0.31946684 |
| 94 | PRKG2 | 0.30452289 |
| 95 | MAP3K7 | 0.30396866 |
| 96 | MAP3K3 | 0.27067158 |
| 97 | RPS6KA1 | 0.26695947 |
| 98 | MAPK7 | 0.24190691 |
| 99 | RPS6KB2 | 0.23892443 |
| 100 | PAK1 | 0.20544662 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 3.44520677 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.20859324 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 3.17340024 |
| 4 | Asthma_Homo sapiens_hsa05310 | 2.90321427 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.47841445 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.37186542 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 2.30839298 |
| 8 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.26823574 |
| 9 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.17750603 |
| 10 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.17642351 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.15706028 |
| 12 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.06950925 |
| 13 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.00977998 |
| 14 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.95562633 |
| 15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.93567208 |
| 16 | Tuberculosis_Homo sapiens_hsa05152 | 1.93557810 |
| 17 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.91984652 |
| 18 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.76821325 |
| 19 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.74693489 |
| 20 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.74174047 |
| 21 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.73876712 |
| 22 | Pertussis_Homo sapiens_hsa05133 | 1.67439228 |
| 23 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.64542255 |
| 24 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.63439748 |
| 25 | Influenza A_Homo sapiens_hsa05164 | 1.61227624 |
| 26 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.59384579 |
| 27 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.52334691 |
| 28 | Legionellosis_Homo sapiens_hsa05134 | 1.48133260 |
| 29 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.45913907 |
| 30 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.44860651 |
| 31 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.42526862 |
| 32 | Measles_Homo sapiens_hsa05162 | 1.41363220 |
| 33 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.35723800 |
| 34 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.35114437 |
| 35 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.33507934 |
| 36 | Lysosome_Homo sapiens_hsa04142 | 1.33247662 |
| 37 | Phagosome_Homo sapiens_hsa04145 | 1.32312817 |
| 38 | Platelet activation_Homo sapiens_hsa04611 | 1.26034712 |
| 39 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.20651247 |
| 40 | Malaria_Homo sapiens_hsa05144 | 1.20452291 |
| 41 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.19794758 |
| 42 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.19455662 |
| 43 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.18393833 |
| 44 | Hepatitis B_Homo sapiens_hsa05161 | 1.18303569 |
| 45 | Viral myocarditis_Homo sapiens_hsa05416 | 1.16594753 |
| 46 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.16448791 |
| 47 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.15994183 |
| 48 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.08954314 |
| 49 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.04180654 |
| 50 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.03453974 |
| 51 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.94996059 |
| 52 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.93047925 |
| 53 | Salmonella infection_Homo sapiens_hsa05132 | 0.91385892 |
| 54 | Shigellosis_Homo sapiens_hsa05131 | 0.86194626 |
| 55 | Apoptosis_Homo sapiens_hsa04210 | 0.85500771 |
| 56 | Ribosome_Homo sapiens_hsa03010 | 0.85319623 |
| 57 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.80543053 |
| 58 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.80346950 |
| 59 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.79855710 |
| 60 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.77326284 |
| 61 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.75257069 |
| 62 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.74137005 |
| 63 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.71406385 |
| 64 | HTLV-I infection_Homo sapiens_hsa05166 | 0.69965688 |
| 65 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.67262021 |
| 66 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.67182677 |
| 67 | Galactose metabolism_Homo sapiens_hsa00052 | 0.66404639 |
| 68 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.65361665 |
| 69 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.62478064 |
| 70 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.60470125 |
| 71 | Prion diseases_Homo sapiens_hsa05020 | 0.59763711 |
| 72 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.58367089 |
| 73 | Amoebiasis_Homo sapiens_hsa05146 | 0.57168490 |
| 74 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.57156879 |
| 75 | Hepatitis C_Homo sapiens_hsa05160 | 0.57021868 |
| 76 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.54716308 |
| 77 | DNA replication_Homo sapiens_hsa03030 | 0.54239310 |
| 78 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.51319292 |
| 79 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.48760700 |
| 80 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.46567762 |
| 81 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.45055023 |
| 82 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.43304763 |
| 83 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.38051950 |
| 84 | Base excision repair_Homo sapiens_hsa03410 | 0.36682904 |
| 85 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.36441731 |
| 86 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.34895486 |
| 87 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.33530484 |
| 88 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.32604117 |
| 89 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.32518818 |
| 90 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.32273385 |
| 91 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.31675247 |
| 92 | Insulin resistance_Homo sapiens_hsa04931 | 0.31212894 |
| 93 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.27282939 |
| 94 | Endocytosis_Homo sapiens_hsa04144 | 0.25564801 |
| 95 | Bladder cancer_Homo sapiens_hsa05219 | 0.25466360 |
| 96 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.23401862 |
| 97 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.23323867 |
| 98 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.22740115 |
| 99 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.22144718 |
| 100 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.21248751 |

